154 related articles for article (PubMed ID: 31106471)
41. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
Silver DL; Jiang XC; Tall AR
J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
[TBL] [Abstract][Full Text] [Related]
42. Induction of carnitine palmitoyl transferase 1 and fatty acid oxidation by retinoic acid in HepG2 cells.
Amengual J; Petrov P; Bonet ML; Ribot J; Palou A
Int J Biochem Cell Biol; 2012 Nov; 44(11):2019-27. PubMed ID: 22871568
[TBL] [Abstract][Full Text] [Related]
43. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
[TBL] [Abstract][Full Text] [Related]
44. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
[TBL] [Abstract][Full Text] [Related]
46. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.
Parolini C; Chiesa G; Zhu Y; Forte T; Caligari S; Gianazza E; Sacco MG; Sirtori CR; Rubin EM
J Biol Chem; 2003 Feb; 278(7):4740-6. PubMed ID: 12471038
[TBL] [Abstract][Full Text] [Related]
47. Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2.
Ieda A; Wada M; Moriyasu Y; Okuno Y; Zaima N; Moriyama T
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202121
[TBL] [Abstract][Full Text] [Related]
48. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
Hsu MH; Savas U; Griffin KJ; Johnson EF
J Biol Chem; 2001 Jul; 276(30):27950-8. PubMed ID: 11371553
[TBL] [Abstract][Full Text] [Related]
49. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
[TBL] [Abstract][Full Text] [Related]
50. Pitavastatin increases ABCA1 expression by dual mechanisms: SREBP2-driven transcriptional activation and PPARα-dependent protein stabilization but without activating LXR in rat hepatoma McARH7777 cells.
Maejima T; Sugano T; Yamazaki H; Yoshinaka Y; Doi T; Tanabe S; Nishimaki-Mogami T
J Pharmacol Sci; 2011; 116(1):107-15. PubMed ID: 21521932
[TBL] [Abstract][Full Text] [Related]
51. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
52. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
[TBL] [Abstract][Full Text] [Related]
53. Effect of TNFalpha on activities of different promoters of human apolipoprotein A-I gene.
Orlov SV; Mogilenko DA; Shavva VS; Dizhe EB; Ignatovich IA; Perevozchikov AP
Biochem Biophys Res Commun; 2010 Jul; 398(2):224-30. PubMed ID: 20599735
[TBL] [Abstract][Full Text] [Related]
54. Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells.
Dashti N; Feng Q; Freeman MR; Gandhi M; Franklin FA
J Nutr; 2002 Sep; 132(9):2651-9. PubMed ID: 12221225
[TBL] [Abstract][Full Text] [Related]
55. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
56. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
57. RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease.
Gilham D; Wasiak S; Tsujikawa LM; Halliday C; Norek K; Patel RG; Kulikowski E; Johansson J; Sweeney M; Wong NC; Gordon A; McLure K; Young P
Atherosclerosis; 2016 Apr; 247():48-57. PubMed ID: 26868508
[TBL] [Abstract][Full Text] [Related]
58. Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene.
Marsh JB; Diffenderfer MR; Fisher EA; Sowden M; Dong M; Paterniti JR; Burkey BF
J Lipid Res; 1996 May; 37(5):1113-24. PubMed ID: 8725162
[TBL] [Abstract][Full Text] [Related]
59. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
Saladin R; Vu-Dac N; Fruchart JC; Auwerx J; Staels B
Eur J Biochem; 1996 Jul; 239(2):451-9. PubMed ID: 8706754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
